Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Leslie T. Cooper, MD
Healthcare Professional Chair
Department of Cardiovascular Diseases
Mayo Clinic
4500 San Pablo Road
Jacksonville, Florida, United States
Leslie T. Cooper, Jr., M.D., is a general cardiologist and the chair of the Mayo Clinic Enterprise Department of Cardiovascular Medicine as well as chair of the Department of Cardiovascular Medicine at Mayo Clinic in Florida. Dr. Cooper’s clinical interests and research focus on clinical and translational studies of rare and undiagnosed cardiomyopathies, myocarditis, and inflammatory cardiac and vascular diseases such as giant cell myocarditis, cardiac sarcoidosis, eosinophilic myocarditis, and Takayasu’s arteritis.
Dr. Cooper is a fellow of the American College of Cardiology, the American Heart Association, and the European Society of Cardiology Heart Failure Association, The International Society for Heart and Lung Transplantation and the Society for Vascular Medicine and Biology.
He is also the founder and former president of the Myocarditis Foundation and continues to serve on their board of directors.
Representative Publications:
Elevated Sera sST 2 Is Associated With Heart Failure in Men<50 Years Old With Myocarditis
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations
Parvovirus B19 in Dilated Cardiomyopathy: There Is More Than Meets the Eye
Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres
Related Content
-
Kevin Barton, MDDr. Kevin Barton is an oncologist in May...
-
Tarek Ashour, MDTarek Ashour is a Nephrologist at Clevel...
-
Icilma Fergus, MDIcilma V. Fergus was recently appointed ...
-
Kunal Bhatt, MDKunal Bhatt, MD, is Assistant Professor ...
-
Farooq H. Sheikh, MDFarooq Sheikh is an attending physician ...
-
Cardiac Amyloidosis – What Is Amyloid and How Does It Affect the Heart?https://www.youtube.com/watch?v=o6u-nETE...
-
Right Ventricular Longitudinal Strain: A Tool for Diagnosis and Prognosis in Light-Chain AmyloidosisObjectives: Light-chain (AL) amyloidosi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.